Ketogenic Diet

What the evidence says

A ketogenic diet restricts carbohydrate enough to make fat-derived ketone bodies a major fuel source. Clinical ketogenic therapy is not simply a high-meat diet: its fat sources, protein allowance, fiber, micronutrients, hydration, and degree of carbohydrate restriction determine both nutritional quality and whether sustained ketosis occurs.^[4][2]

Its clearest medical use is drug-resistant epilepsy, particularly in children. A Cochrane review found that ketogenic approaches increased the chance of seizure freedom or substantial seizure reduction compared with usual care, although certainty ranged from very low to low and intolerance contributed to discontinuation. Therapeutic use requires an epilepsy team and dietitian rather than self-directed dieting.^[1]

Across other randomized evidence, ketogenic diets can reduce body weight, triglycerides, and selected glycemic measures in some populations. Effects depend on the comparator and follow-up: a type 2 diabetes meta-analysis found lower triglycerides but inconsistent 12-month HbA1c results, while an umbrella review judged most associations low or very low certainty. These results do not establish remission, cardiovascular-event prevention, or longer life.^[2][3]

For weight management, very-low-carbohydrate diets are not consistently superior to other calorie-reducing patterns over the long term. The National Lipid Association notes possible advantages for appetite, triglycerides, and medication reduction but also variable LDL-cholesterol responses and little evidence beyond two years. The American Heart Association rates ketogenic patterns as poorly aligned with its guidance because they restrict several food groups and can make adequate fiber and heart-healthy food selection harder.^[4][5]

Constipation, nausea, headache, fatigue, increased urination, and hypoglycemia can occur, and some people experience marked LDL-cholesterol increases. A meta-analysis estimated kidney stones in about 5.9% of people following ketogenic diets in the included clinical settings. Diabetes and blood-pressure medicines may need prompt adjustment; SGLT2 inhibitors are a particular ketoacidosis concern. Pregnancy, advanced kidney or liver disease, pancreatitis, certain metabolic disorders, and eating-disorder risk warrant medical review before restriction begins.^[6][7][4]